Skip to content

CagriSema

peptideInjection

Semaglutide + cagrilintide combo in Phase 3 trials. Strongest weight loss data of any injectable to date, surpassing semaglutide alone through dual appetite/satiety targeting.

Key Facts

  • Classification
    Peptide — Next-gen dual semaglutide + amylin analog with strongest weight loss data.
  • Primary Benefits
    Fat Loss (10/10) · Gut Health (3/10)
  • Administration
    Injection
  • Typical Dose
    2.4 mg semaglutide + 2.4 mg cagrilintide weekly subq. Titrate slowly over several months.
  • Evidence Strength
    Emerging · Community sentiment 7/10

Quick Facts

From price
N/A
Type
peptide
Administration
Injection
Evidence
emerging
Studies referenced
0
Community sentiment
7/10
Stacks with
0 peptides

Top benefits

🔥 Fat Loss
10/10
🫃 Gut Health
3/10
View PricingCompare

Dosing

2.4 mg semaglutide + 2.4 mg cagrilintide weekly subq. Titrate slowly over several months.

Benefit Profile

🔥 Fat Loss
10/10
🫃 Gut Health
3/10